6317101193

disorders]

Wiad Lek. 2001;54(7-8):456-61. Polish.

IF: brak KBN: 5

23.

Raś P. Opala G.

[Burden of caregivers caring for persons with dementia]

Wiad Lek. 2001;54(l-2):94-100. Review. Polish.

IF: brak KBN: 5

24.

Pietrzak I, Opala G.

[The role of camitine in human lipid metabolism]

Wiad Lek. 1998;51(l-2):71-5. Review. Polish.

IF: brak

25.

Opala G, Winter S, Vance C, Vance H, Hutchison HT, Linn LS.

The effect of valproic acid on plasma camitine levels.

Am J Dis Child. 1991 Sep;145(9):999-1001.

IF: brak KBN: 6

brak polskiej afiliacji

26.

Opala G.

[Etiology, occurrence and types of the intemal carotid artery loop]

Neurol Neurochir Pol. 1991 Mar-Apr;25(2): 189-200. Polish.

27.

Opala G.

[Camitine deficiency as an adverse effect of treatment with valproic acid]

Neurol Neurochir Pol. 1990 May-Aug;24(3-4):244-5. Polish. No abstract available.

28.

Opala G, Wajgt A, Bubik M.

[Mortality in vascular diseases of the central nervous in the Katowice province in comparison with other provinces and all Poland (evaluation based on hospital statistical charts)]

Neurol Neurochir Pol. 1989 Mar-Apr;23(2): 121-7. Polish.

29.

Opala G, Wajgt A, Ochudlo S, Marczewska E.

[Eales disease and multiple sclerosis. Case report]

Neurol Neurochir Pol. 1988 JuI-Aug;22(4):340-2. Polish.

30.

Opala G.

[Clinical significance of a vascular loop in the intemal carotid artery]

Neurol Neurochir Pol. 1988 May-Jun;22(3):201-5. Polish.

31.

Opala G, Zbrojkiewicz JS, Ochudlo S, Dragan T, Grzybowski G, Piechota L.

5